Oncternal Therapeutics, Inc. logo

Oncternal Therapeutics, Inc.

Oncternal Therapeutics, is a clinical stage biopharmaceutical company dedicated to the development of novel, first-in-class therapeutics for the treatment of cancer and is located at JLabs, New York.

In June 2016, Oncternal and Tokalas, Inc., merged to create a new world-class clinical-stage oncology company with two promising, first-in-class pipeline products, with operations under the name Oncternal Therapeutics, Inc.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.oncternal.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
3525 Del Mar Heights Rd, #821, CA, 92130-2122
San Diego
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]